These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3039 related articles for article (PubMed ID: 6462628)

  • 1. Enucleation-induced metastasis of intraocular melanomas in mice.
    Niederkorn JY
    Ophthalmology; 1984 Jun; 91(6):692-700. PubMed ID: 6462628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enucleation in consort with immunologic impairment promotes metastasis of intraocular melanomas in mice.
    Niederkorn JY
    Invest Ophthalmol Vis Sci; 1984 Sep; 25(9):1080-6. PubMed ID: 6381375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune rejection of metastases arising from intraocular tumors in mice.
    Niederkorn JY; Knisely TL; Mayhew E
    Invest Ophthalmol Vis Sci; 1986 Sep; 27(9):1355-61. PubMed ID: 3091527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental model for metastasis of intraocular melanoma: preventive role of natural killer cells.
    Yokoyama T; Yoshie O; Mizuno K
    Jpn J Ophthalmol; 1989; 33(1):76-84. PubMed ID: 2733256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracamerally induced concomitant immunity: mice harboring progressively growing intraocular tumors are immune to spontaneous metastases and secondary tumor challenge.
    Niederkorn JY; Streilein JW
    J Immunol; 1983 Nov; 131(5):2587-94. PubMed ID: 6415174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell subsets involved in the rejection of metastases arising from intraocular melanomas in mice.
    Niederkorn JY
    Invest Ophthalmol Vis Sci; 1987 Aug; 28(8):1397-403. PubMed ID: 3497133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic evaluation of spontaneous regression of an intraocular murine melanoma.
    Knisely TL; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1990 Feb; 31(2):247-57. PubMed ID: 2154414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunological analysis of melanoma-specific antigen].
    Wakabayashi S; Okamoto S
    Nihon Hifuka Gakkai Zasshi; 1985 Oct; 95(11):1145-51. PubMed ID: 3879298
    [No Abstract]   [Full Text] [Related]  

  • 9. NKT cells act through third party bone marrow-derived cells to suppress NK cell activity in the liver and exacerbate hepatic melanoma metastases.
    Sadegh L; Chen PW; Brown JR; Han Z; Niederkorn JY
    Int J Cancer; 2015 Sep; 137(5):1085-94. PubMed ID: 25683463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of natural killer cells in intraocular melanoma metastasis.
    Yokoyama T; Yoshie O; Aso H; Ebina T; Ishida N; Mizuno K
    Invest Ophthalmol Vis Sci; 1986 Apr; 27(4):516-8. PubMed ID: 3957568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of MAGE genes in ocular melanoma during progression from primary to metastatic disease.
    Chen PW; Murray TG; Uno T; Salgaller ML; Reddy R; Ksander BR
    Clin Exp Metastasis; 1997 Sep; 15(5):509-18. PubMed ID: 9247253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of anterior chamber-associated immune deviation (ACAID) by allogeneic intraocular tumors does not require splenic metastases.
    Niederkorn JY; Streilein JW
    J Immunol; 1982 Jun; 128(6):2470-4. PubMed ID: 6804562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed-type hypersensitivity but normal cytotoxic T lymphocyte and helper T lymphocyte responses.
    Niederkorn JY; Streilein JW
    J Immunol; 1983 Dec; 131(6):2670-4. PubMed ID: 6196396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Termination of immune privilege in the anterior chamber of the eye when tumor-infiltrating lymphocytes acquire cytolytic function.
    Ksander BR; Mammolenti MM; Streilein JW
    Transplantation; 1991 Jul; 52(1):128-33. PubMed ID: 1907041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
    Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
    Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoregulation of intraocular tumours.
    Niederkorn JY
    Eye (Lond); 1997; 11 ( Pt 2)():249-54. PubMed ID: 9349421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunological analysis of melanoma specific antigen. (I). In-vitro induction of melanoma-antigen specific killer T lymphocytes in primary immune response].
    Wakabayashi S; Taniguchi M; Tomioka H; Okamoto S
    Nihon Hifuka Gakkai Zasshi; 1983 Dec; 93(14):1469-76. PubMed ID: 6676498
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of the metastasis of murine ocular melanoma by natural killer cells.
    Harning R; Koo GC; Szalay J
    Invest Ophthalmol Vis Sci; 1989 Sep; 30(9):1909-15. PubMed ID: 2777511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth and Metastasis of Intraocular Tumors in Aged Mice.
    Han Z; Brown JR; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2016 May; 57(6):2366-76. PubMed ID: 27138736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressed cellular immunity in mice harboring intraocular melanomas.
    Niederkorn JY
    Invest Ophthalmol Vis Sci; 1984 Apr; 25(4):447-54. PubMed ID: 6608506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 152.